Troglitazone reduces plasma levels of tumour necrosis factor-α in obese patients with type 2 diabetes.
Saved in:
| Title: | Troglitazone reduces plasma levels of tumour necrosis factor-α in obese patients with type 2 diabetes. |
|---|---|
| Authors: | Katsuki, A.1, Sumida, Y.1, Murata, K.2, Furuta, M.1, Araki-Sasaki, R.1, Tsuchihashi, K.1, Hori, Y.1, Yano, Y.1, Gabazza, E. C.1, Adachi, Y.1 |
| Source: | Diabetes, Obesity & Metabolism. May2000, Vol. 2 Issue 3, p189-191. 3p. |
| Database: | Academic Search Ultimate |
| ISSN: | 14628902 |
|---|---|
| DOI: | 10.1046/j.1463-1326.2000.00072.x |
